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The safety of a ‘‘core’’ version of esteriﬁed propoxylated glycerols (EPGs) was assessed in a developmental
toxicity study in New Zealand white rabbits, Hra:(NZW)SPF. Four groups each of 18 inseminated female
rabbits received diets ad libitum containing concentrations of 0%, 2.5%, 5%, and 10% EPG (w/w) with 6%
corn oil (w/w). No treatment-related effects were observed in any maternal toxicity parameter, including
maternal body weight and weight gain, feed consumption, or clinical signs of toxicity. There were no sta-
tistically signiﬁcant treatment-related effects in gestational parameters, including pre- and post-implan-
tation loss, litter size, sex ratio, fetal body weight, and crown–rump length. The incidences of fetal
external, visceral, and skeletal malformations or variations were also comparable across groups. A no-
observable-adverse-effect level (NOAEL) of 10% EPG (approximately 4.76 g/kg bw/day) for both maternal
and developmental toxicity is proposed based on the results of this study.
 2014 Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecom-
mons.org/licenses/by-nc-nd/3.0/).1. Introduction
Esteriﬁed propoxylated glycerols (EPGs) represent a family of
fat- and oil-like substances, resembling triglycerides in structure
and appearance, but modiﬁed to prevent or limit their digestion
when consumed in food. They consist of multiple propylene glycol
units inserted between the glycerol and fatty acid moieties of fats
and oils. Their poor absorption results in a low- to no-calorie pro-
ﬁle when substituted for fat in the diet.
The present study examined the potential of a version of EPG
that is considered the ‘‘core’’ version (H-EPG-05-HR/SO 9:1) to
affect offspring development when administered in the feed to
female New Zealand white rabbits.2. Materials and methods
This study was sponsored by ARCO Chemical Company, Newton
Square, Pennsylvania, and conducted at Research Triangle Institute
(RTI), Research Triangle Park, North Carolina, from September 22,
1992 to November 13, 1992, in compliance with the Principles of
Good Laboratory Practice (GLP) regulations of the United States
Food and Drug Administration (FDA), the Organization for Eco-nomic Cooperation and Development (OECD), and the Japanese
Ministry of Health and Welfare (MHW).2.1. Animals
Eighty (80) nulliparous female New Zealand white rabbits,
Hra:(NZW)SPF (age: 5.5 months; body weight: 2.5–5 kg) were
obtained from Hazelton Research Products, Inc. (Denver, PA). Eight
(8) were chosen randomly for quality control to assess overall
health (assessment of skin, fur, eyes, etc.; serology, hematology,
histopathology, etc.); the results were within the normal range,
based on the laboratory historical control records. The remaining
animals were allowed to acclimate to the laboratory environment
for approximately 2 weeks before being stratiﬁed by body weight
and allocated to four treatment groups, 18 animals each.2.2. Mating
Doe rabbits assigned to the various treatment groups and
exposed to the appropriate feed for 1 week (starting on day-7)
were then artiﬁcially inseminated (Hafez, 1970). To induce ovula-
tion, the females received an intravenous (i.v.) injection of Preg-
nyl (chorionic gonadotropin) (0.1 ml/kg; Organon, Inc., West
Orange, NJ) prior to insemination. Semen was collected from the
RTI rabbit breeding colony males using an artiﬁcial vagina
(Bredderman et al., 1964) in conjunction with a teaser female
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Fig. 1. Overview of the study design.
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the males was evaluated for number of motile sperm. Females
were inseminated between 1:00 and 5:00 PM with approximately
0.25–0.50 mL of undiluted ejaculate. The date of insemination was
designated gestational day (GD) 0. Three mating days were
employed to allow 3 days of scheduled necropsy on GD 30, with
examination of 24 does (6/group) and their fetuses on each nec-
ropsy day. Sperm from a given male rabbit was not used to insem-
inate more than two females in any given treatment group.
2.3. Housing
Animals were housed singly in stainless steel cages with mesh
ﬂooring. Environmental controls for the animal room were set to
maintain 68–75 F, a relative humidity of 40–70%, and a 12-h
light/12-h dark cycle. Variations from these conditions were docu-
mented and were considered to have no effect on the outcome of
the study. Water was provided ad libitum; feed was provided as a
ﬁxed daily ration. There were no known contaminants in the food
or water that would have interfered with this study.
2.4. Test materials
The test material, esteriﬁed propoxylated glycerol [H-EPG-05
HR/SO 9:1; EPG (stabilized with tocopherols, including a-tocoph-
erol), lot # 753489] was provided by the sponsor. The test article
was a white-colored, odorless solid, received frozen, and stored
in the original containers at 20 ± 5 C. The purity, as provided
by the supplier, was 99.6% (for the purposes of concentration cal-
culations, the purity was assumed to be 100%).
The vehicle, Mazola corn oil, was received from Best Foods, A
Division of CPC International, Inc., 1120 Commerce Avenue, Union,
NJ 07083. According to the supplier, all cases of corn oil came fromthe same lot (Lot No. 2321) of material. The vehicle was received
frozen and stored at 20 ± 5 C. The characterization data were
provided by the supplier (100% total fatty acids by GC analysis as
methyl esters) and the purity was assumed to be 100% for the pur-
pose of concentration calculations.
The carrier was Modiﬁed Purina Certiﬁed Rabbit Chow No. 5322
with no added soy oil, designated by the supplier as 5744M-Y,
manufactured by Purina Test Diets, Incorporated, Richmond, IN
47375. The soybean oil normally added to the diet was omitted
and replaced with corn meal by the vendor. Corn oil was added
to the basic diet at 6% (w/w) such that the total lipid content of
the diet was approximately 8%.The remaining endogenous fat con-
tributed by the other ingredients comprised 2.14–2.30%. The
remaining major components included 17% protein, 18% ﬁber,
12% moisture, 8% ash, and about 2% added minerals. Each shipment
was logged in at RTI and stored in temperature- and humidity-reg-
ulated rooms at approximately 65F (18 C) and 50% relative
humidity; the feed lots were used within 6 months of the milling
date.
2.5. Feed formulation
Study feeds were formulated in a 5-ft3 V-shell blender (Model
No. CV-5, Lowe Industries, Crestwood, IL) at RTI by blending
approximately one-half of the total blend ﬁrst, then the premix
(corn oil or corn oil/EPG blend), followed a small amount of the
total blend (usually 5% of the total blend weight to ‘‘rinse’’ the pre-
mix container), and the remainder. Corn oil was used as is for the
control feed; EPG was melted into corn oil at 40–60 C for an aver-
age of 20 min before being added to the test feeds. The prepared
diet was blended for 0.75–1.25 h, depending on the size of the
batch formulated. The diets were then pelleted (Model CL-3, Cali-
fornia Pellet Mill Co., Crawfordville, IN), and a 1/800  1–1/400 NZR
Table 1
Fate of does in the study.
% EPG in feed
0 2.5 5 10
Total treated 18 18 18 18
Removeda 1 0 0 1
Found dead or euthanized 0 0 0 0
Not pregnant at sacriﬁce 3 3 0 2
Pregnant at sacriﬁce 14
(82.4%)
15
(83.3%)
18
(100%)
15
(88.2%)
a One doe each in the 0% and 10% EPG groups were removed because they had
delivered before the scheduled sacriﬁce day (GD 30).
Table 2
Mean maternal body weights (g) during gestation.
% EPG in feed
0 2.5 5 10
N = 14 N = 15 N = 18 N = 15
GD 0 3749 ± 78 3747 ± 100 3693 ± 65 3719 ± 82
GD 1 3777 ± 78 3770 ± 105 3704 ± 65 3748 ± 88
GD 2 3798 ± 81 3799 ± 100 3728 ± 67 3758 ± 86
GD 3 3836 ± 83 3849 ± 105 3768 ± 69 3795 ± 86
GD 4 3863 ± 81 3868 ± 100 3779 ± 69 3819 ± 81
GD 5 3889 ± 76 3896 ± 101 3819 ± 68 3841 ± 88
GD 6 3902 ± 77 3904 ± 99 3835 ± 67 3876 ± 85
GD 7 3934 ± 83 3933 ± 96 3831 ± 66 3901 ± 84
GD 8 3966 ± 83 3942 ± 88 3858 ± 68 3920 ± 88
GD 9 3979 ± 77 3947 ± 83 3884 ± 67 3948 ± 85
GD 10 3981 ± 80 3975 ± 80 3899 ± 70 3967 ± 84
GD 11 3994 ± 80 3994 ± 78 3924 ± 67 3976 ± 84
GD 12 4019 ± 83 3983 ± 75 3897 ± 59 3983 ± 85
GD 13 4018 ± 75 3994 ± 82 3956 ± 67 3995 ± 85
GD 14 4015 ± 82 4067 ± 78 3999 ± 66 4043 ± 84
GD 15 4107 ± 85 4103 ± 85 4064 ± 71 4089 ± 87
GD 16 4138 ± 85 4125 ± 85 4091 ± 70 4089 ± 89
GD 17 4139 ± 89 4117 ± 90 4096 ± 72 4097 ± 85
GD 18 4156 ± 84 4113 ± 88 4104 ± 72 4106 ± 91
GD 19 4147 ± 82 4129 ± 90 4119 ± 70 4125 ± 92
GD 20 4196 ± 86 4167 ± 92 4158 ± 73 4135 ± 95
GD 21 4205 ± 88 4167 ± 91 4174 ± 74 4148 ± 92
GD 22 4214 ± 84 4183 ± 90 4186 ± 76 4155 ± 96
GD 23 4246 ± 89 4206 ± 89 4187 ± 75 4182 ± 93
GD 24 4249 ± 91 4199 ± 90 4196 ± 78 4187 ± 92
GD 25 4271 ± 91 4201 ± 84 4212 ± 77 4207 ± 93
GD 26 4260 ± 84 4189 ± 82 4209 ± 74 4208 ± 90
GD 27 4276 ± 84 4185 ± 78 4207 ± 76 4192 ± 98
GD 28 4292 ± 84 4187 ± 80 4209 ± 76 4211 ± 100
GD 29 4309 ± 88 4210 ± 78 4229 ± 74 4217 ± 91
GD 30a 4308 ± 85 4229 ± 82 4242 ± 74 4236 ± 92
Values are reported as the mean ± SEM. Includes all does pregnant at terminal
sacriﬁce.
a Body weights of the live does in the room at time of weighing feed for GD 30.
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temperature, packaged in polyethylene bags, and stored appropri-
ately (as determined by a storage stability study) prior to analyses
and presentation to the animals. Analytical samples were collected
from the beginning, middle and end of each pellet run for homoge-
neity evaluations. Aliquots were also taken for stability studies.
Samples from pelleted feed formulated as described, at 2.5% and
10.0% EPG, were homogeneous and stable for at least 30 days at
refrigerated temperatures (1–7 C) and for 49 days at freezer tem-
peratures (12 to 18 C). Formulations of pelleted feed were also
evaluated for stability under ambient conditions: in a feed jar in a
cage, exposed to air, normal room lighting and temperatures of
22–26 C. These formulations were stable under these conditions
for at least 9 days.
Analysis revealed lipid levels (corn oil plus EPG) of 96.4–113% of
target, and a-tocopherol of 89–112% of target (52.0–53.7 ppm in
control feed; 860 ppm in EPG feed); EPG levels were 90.2–98% of
target.
2.6. Dietary level selection and study design
The study was conducted with three (3) treatment groups and a
vehicle control group, each comprised of 18 inseminated female
rabbits. EPG was administered in the feed at 0% (vehicle control),
2.5%, 5% and 10% (w/w). These levels were selected based on
results of a prior palatability/dose range-ﬁnding study in pregnant
rabbits. Due to the non-caloric nature of EPG, levels greater than
10% were considered likely to interfere with the proper nutrition
of the animals, by diluting the diet.
Fig. 1 provides an overview of the study design. The exposure
period was approximately 26 days, starting 1 week (day-7) prior
to insemination and, GD 0 through GD 18 (to the morning of GD
19). Water was available ad libitum throughout the study, 7 days
per week. Control diet was administered to all study females from
day-22 to day-7 and from the morning of GD 19 until terminal
sacriﬁce on GD 30.
2.7. In-life observations
Cage-side observations for mortality and moribundity were
made twice daily (morning and afternoon). No animals died or
were euthanized in moribund condition. Two does delivered pre-
maturely on the morning of scheduled sacriﬁce, GD 30. They were
euthanized and necropsied on the day they delivered.
Cage-side observations included examination of the general
condition, appearance, and behavior of each rabbit; observation
of the animal’s movement within the cage, inspection of the cages
for overall condition, cleanliness, and evidence of excreta; any evi-
dence of feed wastage; and visual inspection of the feces for
appearance, consistency, and any evidence of phase separation
(i.e., appearance of oily layers or deposits in the stools). Any epi-
sodes of diarrhea were adequately documented and the probable
cause established, if possible.
Body weights were measured on study day-14 and daily there-
after until GD 30. Maternal body weight gains during pre-
treatment (days-14 to -7), treatment (days-7 to GD 0; GD 0 to
19), post-treatment (GD 19 to GD 30), and gestation (GD 0 to 30)
were calculated. Feed consumption was recorded daily.
2.8. Necropsy and fetal evaluations
On GD 30, approximately one to one and a half days before
expected parturition, all surviving female rabbits were euthanized
by i.v. (marginal ear vein) injection of pentobarbital sodium Eutha-
nasia-6 Injection CII (Anthony Products Co., Arcadia, CA). Thoracic
and abdominal cavities and organs were examined, and pregnancystatus was conﬁrmed by uterine examination. Uteri that presented
no visible implantation sites were stained with ammonium sulﬁde
(10%) to visualize any early resorptions (Salewski, 1964). At sacri-
ﬁce, the body and liver of each inseminated female were weighed.
The left ovary was removed (to allow correct orientation of the
uterus once removed from each animal); the uterus with the
attached right ovary was then removed and weighed. All does in
all groups were then subjected to a gross pathological examination
that included examination of external surfaces; all oriﬁces; cranial
cavity; carcass; external and cut surfaces of the brain and spinal
cord; the thoracic, abdominal, and pelvic cavities and their viscera;
and cervical tissues and organs. Since no treatment-related gross
lesions were observed, no histopathologic evaluations were
performed.
Ovarian corpora lutea were counted, and uterine contents (i.e.,
number of implantation sites, early, middle and late resorptions,
dead fetuses, live fetuses) were recorded. Early resorptions
Table 3
Mean maternal body weight change (g), and uterine and liver weights.
% EPG in feed
0 2.5 5 10
N = 14 N = 15 N = 18 N = 15
Body weight change Days-14 to -7 424 ± 29 386 ± 16 433 ± 21 367 ± 29
Day-7 to GD 0 176 ± 26§ 166 ± 28 94 ± 24 113 ± 21
GD 0–19 398 ± 33 382 ± 44 427 ± 29 406 ± 31
GD 19–30 161 ± 23 99 ± 40 122 ± 18 111 ± 37
GD 30a 4230 ± 85 4165 ± 82 4193 ± 72 4174 ± 94
GD 0–30a 481 ± 48 418 ± 47 500 ± 28 455 ± 44
Body weight change (corrected)b 34.3 ± 49.4 31.1 ± 80.1 47.6 ± 53.7 28.2 ± 53.0
Gravid uterine weight 446.7 ± 59.2 386.2 ± 51.3 452.1 ± 37.9 427.2 ± 52.2
Maternal liver weight 110.2 ± 3.7 121.4 ± 6.5 112.6 ± 3.7 104.5 ± 4.4
Relative maternal liver weight (percent body weight) 2.62 ± 0.11 2.91 ± 0.14 2.69 ± 0.08 2.50 ± 0.08
Values are reported as the mean ± SEM. Includes all does pregnant at terminal sacriﬁce.
a Based on body weights after sacriﬁce on GD 30.
b Body weight change from GD 0 to sacriﬁce weight on GD 30 minus gravid uterine weight.
§ p < 0.05; Test for Linear Trend.
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consisted of metrial glands with or without placentae (maternal
and/or fetal components); middle resorptions included some fetal
tissue in addition to metrial glands and placentae; late (and full)
resorptions included a fetus with discernible limb buds, no vital
signs, and a weight <10 g. A designation of dead fetus was used
for a fetus with discernible digits, no vital signs, and a weight
P10 g. For this study, middle, late and full resorptions were pooled
under the heading of ‘‘late resorptions’’.
Live fetuses were dissected from the uterus and immediately
euthanized by intraperitoneal injection of pentobarbital sodium.
Fetal parameters evaluated included live pups/litter, sex, weight,
crown–rump length, and external morphological abnormalities,
including cleft palate. Approximately one-half of the live fetuses
per litter were decapitated after dissection, and the heads were
ﬁxed in Bouin’s solution for sectioning and examination of soft tis-
sue craniofacial alterations; carcasses were eviscerated and exam-
ined for skeletal malformations and variations after staining with
alcian blue/alizarin red S.
2.9. Statistics
The unit of comparison was the female, pregnant female, or the
litter. Quantitative continuous data (e.g., maternal body weights,
fetal body weights, feed consumption) were compared for each
of the three treatment groups to the one vehicle control group by
the use of Bartlett’s test for homogeneity of variances. Data within
groups were also evaluated for normality. If Bartlett’s test indi-
cated lack of homogeneity of variances (i.e., p < 0.001) or, if the test
for normality was rejected for the majority of the groups, then non-
parametric statistical tests were employed for the continuous vari-
ables (Winer, 1962). If Bartlett’s test indicated homogeneous
variances (i.e., p > 0.001) and the data were normally distributed,
then parametric statistical tests were employed for the continuous
variables. Appropriate General Linear Models (GLM) procedures
(SAS Institute Inc., 1989a,b, 1990a,b,c) for the analysis of variance
(ANOVA) were used. Prior to GLM analysis, an arcsine-square root
transformation was performed on all litter-derived percentage
data (Snedecor and Cochran, 1967) to allow the use of parametric
methods. For these litter-derived percentage data, the ANOVA was
weighted according to litter size. GLM analysis was used to deter-
mine the signiﬁcance of the dosage-response relationship (Test for
Linear Trend), and to determine whether signiﬁcant dosage effects
had occurred for selected measures (ANOVA). When a signiﬁcant
(p < 0.05) main effect for dosage occurred, Dunnett’s Multiple Com-
parison Test (Dunnett, 1955, 1964) was used to compare each EPG-exposed group to the control group for that measure. A one-tailed
test (i.e., Dunnett’s Test) was used for all pairwise comparisons to
the designated control group, except that a two-tailed test was
used for maternal body and organ weight parameters, maternal
feed consumption, fetal body weight, crown–rump length, and
percent males per litter. Nonparametric tests used included the
Kruskal–Wallis Test to determine if signiﬁcant differences were
present among the groups, followed by the Mann–Whitney U test
for pairwise comparisons to the designated control group, if the
Kruskal–Wallis test was signiﬁcant (Siegel, 1956). Jonckheere’s test
for k independent samples (Jonckheere, 1954) was used to identify
signiﬁcant concentration–response trends for nonparametric
continuous data. Nominal scale measures were analyzed by Chi-
Square Test for Independence for differences among treatment
groups, and by the Cochran–Armitage Test for Linear Trend on Pro-
portions (Cochran, 1954; Armitage, 1955; Agresti, 1990). When
Chi-Square revealed signiﬁcant (p < 0.05) differences among
groups, then a two-tailed Fisher’s Exact Probability Test, with
appropriate adjustments for multiple comparisons, was used for
pairwise comparisons between each EPG-exposed group and the
vehicle control group (Snedecor and Cochran, 1967).
A test for statistical outliers was performed on maternal body
weights and feed consumption (g/day). If examination of pertinent
study data did not provide a plausible, biologically sound reason
for inclusion of the data ﬂagged as ‘‘outlier,’’ the data were
excluded from summarization and analysis. If feed consumption
data were negative for a given doe and day, they were designated
as ‘‘unrealistic’’ and excluded from summarization and analysis. If
feed consumption data for a given observational interval (e.g., daily
during treatment) were designated outliers or unrealistic, then
summarized data encompassing this period did not include this
value.
3. Results
3.1. Fate of doe rabbits on study
The performance of does in this study is summarized in Table 1.
One doe each at 0% and 10% EPG was removed from the study due
to delivery prior to the scheduled sacriﬁce (early on GD 30). No
does died or aborted. Eight (8) does were not pregnant at sched-
uled sacriﬁce, including three (3) each at 0% and 2.5% EPG, and
two (2) at 10% EPG. Pregnancy rates were 82.4%, 83.3%, 100%,
and 88.2%, respectively, at each EPG concentration. Fully resorbed
litters were observed in all groups: two (2) each at 0%, 2.5%, and
10% EPG, and one (1) at 5% EPG. The numbers of litters (fetuses)
Table 4
Feed consumption (g/kg bw/day).
% EPG in feed
0 2.5 5 10
N = 14 N = 15 N = 18 N = 15
Day-14 to -7 61.3 ± 1.6a,§ 59.0 ± 1.1b 60.5 ± 1.3a 56.3 ± 2.2
Day-7 to -6 57.3 ± 2.3 57.6 ± 3.5 56.1 ± 2.3 54.8 ± 2.1
Day-6 to -5 53.0 ± 2.3 54.8 ± 2.0 51.4 ± 1.7a 51.1 ± 2.8
Day-5 to -4 51.8 ± 1.7 54.7 ± 4.0 53.5 ± 1.8 47.4 ± 2.4
Day-4 to -3 53.0 ± 1.9 54.2 ± 1.6a 54.9 ± 2.2 50.9 ± 3.1a
Day-3 to -2 52.4 ± 2.4 51.9 ± 2.2 49.5 ± 2.2a 47.9 ± 2.2
Day-2 to -1 50.6 ± 2.5 47.9 ± 2.0 50.8 ± 2.2a 48.2 ± 3.0a
Day-1 to GD 0 48.7 ± 2.1 51.5 ± 3.5 51.6 ± 2.3 48.4 ± 2.7
Day-7 to GD 0 52.4 ± 1.8 52.5 ± 1.5a 51.6 ± 1.6b 49.3 ± 2.1a
GD 0 to 1 49.4 ± 2.4 42.9 ± 2.7 46.6 ± 3.6 49.4 ± 2.7
GD 1 to 2 49.8 ± 2.4 51.2 ± 3.8 51.0 ± 3.0 48.0 ± 3.3
GD 2 to 3 47.8 ± 1.6 47.9 ± 2.5 47.9 ± 2.0 47.2 ± 2.2
GD 3 to 4# 48.7 ± 1.2 48.6 ± 4.6 46.9 ± 2.5 48.7 ± 1.9
GD 4 to 5 47.8 ± 1.5 49.7 ± 3.3 50.8 ± 2.1 49.5 ± 3.0
GD 5 to 6 51.5 ± 1.7 46.6 ± 1.8b 51.3 ± 2.5 53.4 ± 2.5
GD 6 to 7 50.4 ± 1.9 52.0 ± 4.0 47.0 ± 3.9a 55.9 ± 2.4
GD 7 to 8 49.2 ± 1.7 47.7 ± 4.7 52.8 ± 2.6 51.3 ± 2.4
GD 8 to 9 49.2 ± 2.1 47.3 ± 4.2 48.6 ± 2.4 52.8 ± 2.4
GD 9 to 10 45.8 ± 2.4 47.9 ± 4.2 51.5 ± 2.7 49.8 ± 2.0
GD 10 to 11# 44.6 ± 1.3¥ 47.7 ± 4.0 50.5 ± 3.2 51.0 ± 1.9
GD 11 to 12# 45.5 ± 1.3 43.3 ± 4.3 45.1 ± 3.3 45.7 ± 2.1
GD 12 to 13 39.3 ± 2.5 45.8 ± 1.9 41.0 ± 2.2 43.7 ± 2.3
GD 13 to 14 41.1 ± 3.9 44.0 ± 3.4 43.5 ± 3.5 44.1 ± 1.9
GD 14 to 15 42.9 ± 2.6a 42.9 ± 2.8 43.6 ± 2.7 41.5 ± 2.5
GD 15 to 16 45.4 ± 2.1 43.1 ± 3.4 46.5 ± 3.2 40.6 ± 3.5
GD 16 to 17 40.6 ± 2.2 37.1 ± 3.1 43.5 ± 1.9 40.7 ± 2.9
GD 17 to 18 40.4 ± 1.7 40.0 ± 3.7 47.0 ± 2.4 44.3 ± 2.8a
GD 18 to 19 41.3 ± 1.6 41.4 ± 2.3 45.0 ± 2.3 42.2 ± 3.1
GD 0 to 19 45.9 ± 0.9a 43.6 ± 1.6b 45.9 ± 1.5a 47.6 ± 1.7a
GD 19 to 20 44.4 ± 2.1 44.9 ± 2.7 47.1 ± 3.4 40.7 ± 1.8a
GD 20 to 21 42.1 ± 1.5 40.1 ± 2.0 43.3 ± 2.1 41.8 ± 2.4a
GD 21 to 22 36.7 ± 1.7 38.4 ± 2.3 39.8 ± 1.7a 38.1 ± 1.5b
GD 22 to 23 38.7 ± 2.1 37.0 ± 3.4 35.3 ± 2.3 36.3 ± 1.6a
GD 23 to 24 33.0 ± 2.0 31.3 ± 3.9 29.9 ± 2.5 34.5 ± 2.5a
GD 24 to 25 28.2 ± 2.4a 27.6 ± 4.6 27.9 ± 2.7a 31.7 ± 1.9c
GD 25 to 26 27.3 ± 2.4 24.6 ± 4.0 23.4 ± 2.9b 22.9 ± 3.6e
GD 26 to 27 23.8 ± 2.1c 21.0 ± 2.8a 22.6 ± 1.4c 25.1 ± 3.9b
GD 27 to 28 28.7 ± 2.1 28.4 ± 4.3 25.8 ± 1.7 28.0 ± 3.0a
GD 28 to 29 28.2 ± 1.7 28.0 ± 4.1 27.6 ± 2.0 28.8 ± 2.9a
GD 29 to 30 25.8 ± 2.1 27.4 ± 2.9 23.8 ± 2.7 26.4 ± 2.6b
GD 19 to 30 30.7 ± 1.5d 29.7 ± 1.8a 30.0 ± 1.4d 31.3 ± 1.8f
GD 0 to 30 39.8 ± 1.2d 38.3 ± 0.8b 39.5 ± 1.2d 39.8 ± 1.2f
Values are reported as the mean ± SEM.
Decreases in Nwere due to one or more of the following: the doe scratched feed out
of the feed hopper into the pan and therefore an accurate weight could not be
obtained, the feed was accidently spilled on the ﬂoor prior to weighing, or the feed
consumption value was a statistical outlier and therefore was not included.
a Data from one animal omitted.
b Data from two animals omitted.
c Data from three animals omitted.
d Data from four animals omitted.
e Data from ﬁve animals omitted (continued).
f Data from six animals omitted.
# Bartlett’s test for homogeneity of variances was either signiﬁcant (p < 0.001) or
there was zero variance in one or more groups, so the test could not be done and/or
the test for normality was rejected for the majority of the groups; therefore, non-
parametric statistical tests were employed for evaluation of the data.
§ p < 0.05; Test for Linear Trend.
¥ p < 0.05; Jonckheere’s Test.
Table 5
EPG intake (g/kg bw/day).
% EPG in feed
0 2.5 5 10
N = 14 N = 15 N = 18 N = 15
Day-7 to -6 0 1.44 ± 0.09 2.81 ± 0.11 5.48 ± 0.21
Day-6 to -5 0 1.37 ± 0.05 2.57 ± 0.08a 5.11 ± 0.28
Day-5 to -4 0 1.37 ± 0.10 2.67 ± 0.09 4.74 ± 0.24
Day-4 to -3 0 1.35 ± 0.04a 2.74 ± 0.11 5.09 ± 0.31a
Day-3 to -2 0 1.30 ± 0.06 2.47 ± 0.11a 4.79 ± 0.22
Day-2 to -1 0 1.20 ± 0.05 2.54 ± 0.11 4.82 ± 0.30a
Day-1 to GD 0 0 1.29 ± 0.09 2.58 ± 0.11 4.84 ± 0.27
Day-7 to GD 0 0 1.31 ± 0.04a 2.58 ± 0.08a 4.93 ± 0.21a
GD 0–1 0 1.07 ± 0.07 2.33 ± 0.18 4.94 ± 0.27
GD 1–2 0 1.28 ± 0.09 2.55 ± 0.15 4.80 ± 0.33
GD 2–3 0 1.20 ± 0.06 2.39 ± 0.10 4.72 ± 0.22
GD 3–4 0 1.22 ± 0.12 2.35 ± 0.13 4.87 ± 0.19
GD 4–5 0 1.24 ± 0.08 2.54 ± 0.10 4.95 ± 0.30
GD 5–6 0 1.17 ± 0.05b 2.56 ± 0.13 5.34 ± 0.25
GD 6–7 0 1.30 ± 0.10 2.35 ± 0.19a 5.59 ± 0.24
GD 7–8 0 1.19 ± 0.12 2.64 ± 0.13 5.13 ± 0.24
GD 8–9 0 1.18 ± 0.10 2.43 ± 0.12 5.28 ± 0.24
GD 9–10 0 1.20 ± 0.10 2.57 ± 0.14 4.98 ± 0.20
GD 10–11 0 1.19 ± 0.10 2.52 ± 0.16 5.10 ± 0.19
GD 11–12 0 1.08 ± 0.11 2.26 ± 0.17 4.57 ± 0.21
GD 12–13 0 1.14 ± 0.05 2.05 ± 0.11 4.37 ± 0.23
GD 13–14 0 1.10 ± 0.09 2.18 ± 0.18 4.41 ± 0.19
GD 14–15 0 1.07 ± 0.07 2.18 ± 0.13 4.15 ± 0.25
GD 15–16 0 1.08 ± 0.08 2.33 ± 0.16 4.06 ± 0.35
GD 16–17 0 0.93 ± 0.08 2.17 ± 0.10 4.07 ± 0.29
GD 17–18 0 1.00 ± 0.09 2.35 ± 0.12 4.43 ± 0.28a
GD 18–19 0 1.03 ± 0.06 2.25 ± 0.11 4.22 ± 0.31
GD 0–19 0 1.09 ± 0.04b 2.29 ± 0.08a 4.76 ± 0.17a
Values are reported as the mean ± SEM.
EPG was not administered during days-14 to -7 or GD 19–30; animals received the
basal diet plus 6% added corn oil.
Decreases in Nwere due to one or more of the following: the doe scratched feed out
of the feed hopper into the pan and therefore an accurate weight could not be
obtained, the feed was accidently spilled on the ﬂoor prior to weighing, or the feed
consumption value was a statistical outlier and therefore was not included.
a Data from one animal omitted.
b Data from two animals omitted.
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(89), respectively.
3.2. Maternal body weights
There were no statistically-signiﬁcant or biologically-relevant
changes in maternal body weights in terms of pairwise compari-
sons or concentration-related trends at any time point evaluated
from day-14 through GD 30. Maternal weight changes were alsoequivalent among groups during pre-treatment (days-14 to -7),
treatment (days-7 to GD 0; GD 0 to 19), post-treatment (GD 19
to GD 30), and gestation (GD 0 to 30, Table 2). There was a signif-
icant, concentration-related downward trend in weight changes on
day-7 to GD 0, but with no signiﬁcant pairwise comparisons. Mean
values for maternal gestational weight changes (GD 0 to GD 30),
corrected for the weight of the gravid uterus, were equivalent
across all groups. Maternal gravid uterine weight and liver weight
(absolute and relative to body weight) were also equivalent across
all groups (Table 3).3.3. Maternal clinical observations
There were no treatment- or concentration-related clinical
observations in any doe at any time. The recurring observations
of soft feces and/or feces matted to cage grill (indirect evidence
for soft feces) were made in all groups (data not shown), most
likely due to the corn oil in all the test diets. Clinical weight loss
(deﬁned as weight loss P150 g in any one period) was observed
in three (3), eight (8), eight (8), and four (4) animals each from
the 0%, 2.5%, 5%, and 10% EPG groups, respectively, during exposure
(day-7 to GD 19); and in one doe at 10% EPG during the post-expo-
sure period (GD 19 to GD 30). However, no treatment or concentra-
tion-related ﬁndings were noted upon gross examination of all
dams at scheduled sacriﬁce on GD 30.
Table 6
Summary of litter data and fetal measurements.
% EPG in feed
0 2.5 5 10
All littersa 14 15 18 15
Corpora lutea (per doe) 12.57 ± 0.64 12.07 ± 0.71 11.06 ± 0.49 12.73 ± 1.08
Implantations (sites per litter) 6.93 ± 0.73 6.07 ± 0.69 7.28 ± 0.66 6.73 ± 0.75
% Preimplantation (loss per litter) 44.84 ± 5.67 45.80 ± 7.29 33.78 ± 5.46 41.49 ± 7.09
Early resorptions (per litter) 1.00 ± 0.42 0.87 ± 0.39 0.72 ± 0.24 0.67 ± 0.21
% Early resorptions (per litter)# 21.23 ± 9.75 18.89 ± 9.20 12.27 ± 5.52 18.12 ± 8.78
Litters with early resorptions 5 (35.71%) 5 (33.33%) 9 (50%) 7 (46.67%)
Late resorptions (per litter) 0 0 0 0.13 ± 0.09
% Late resorptions (per litter)# 0 0 0 1.94 ± 1.34
Litters with late resorptions 0 0 0 2 (13.33%)
Resorptions (per litter) 1.00 ± 0.42 0.87 ± 0.39 0.72 ± 0.24 0.80 ± 0.22
% Resorptions (per litter)# 21.23 ± 9.75 18.89 ± 9.20 12.27 ± 5.52 20.06 ± 8.74
Litters with resorptions 5 (35.71%) 5 (33.33%) 9 (50%) 8 (53.33%)
Late fetal deaths (per litter) 0 0 0.06 ± 0.06 0
% Late fetal deaths (per litter)# 0 0 0.43 ± 0.43 0
Litters with late fetal deaths 0 0 1 0
% Litters with late fetal deaths 0 0 5.56 0
Non-live implants (per litter)b 1.00 ± 0.42 0.87 ± 0.39 0.78 ± 0.24 0.80 ± 0.22
% Non-live implants (per litter)b,# 21.23 ± 9.75 18.89 ± 9.20 12.69 ± 5.48 20.06 ± 8.74
Litters with non-live implantsb 5 (35.71%) 5 (33.33%) 10 (55.56%) 8 (53.33%)
Adversely affected implants (per litter)c 1.36 ± 0.44 1.00 ± 0.38 0.83 ± 0.23 0.93 ± 0.25
% Adversely affected implants (per litter)c,# 25.79 ± 9.49 20.67 ± 9.02 13.80 ± 5.44 22.51 ± 8.81
Litters with adversely affected implantsc 8 (57.14%) 7 (46.67%) 11 (61.11%) 9 (60%)
Live littersd 12 13 17 13
Live fetuses per litter 6.92 ± 0.67 6.00 ± 0.72 6.88 ± 0.62 6.85 ± 0.61
% Male fetuses per litter 46.95 ± 5.97 56.02 ± 6.00 49.96 ± 5.42 45.67 ± 6.04
Male fetuses per litter 3.42 ± 0.51 3.08 ± 0.40 3.47 ± 0.56 3.38 ± 0.60
Female fetuses per litter 3.50 ± 0.48 2.92 ± 0.64 3.41 ± 0.48 3.46 ± 0.33
Average fetal body weight (g) per litter 53.80 ± 1.72 53.13 ± 1.89 50.56 ± 2.02 49.61 ± 1.02
Average male fetal body weight (g) per litter 55.24 ± 1.79§ 54.33 ± 2.04 51.75 ± 2.23 49.41 ± 1.40
Average female fetal body weight (g) per litter 52.59 ± 1.73 51.55 ± 1.82 48.60 ± 2.17 49.18 ± 1.22
Bartlett’s (p = 0.0910); DOSE (p = 0.2199); SEX (p = 0.0005); DOSE  SEX (p = 0.3072).
Average fetal crown rump length (cm) per litter 10.3 ± 0.1 10.2 ± 0.1 10.1 ± 0.2 9.9 ± 0.1
Average male fetal crown rump length (cm) per litter 10.4 ± 0.2 10.3 ± 0.2 10.2 ± 0.2 9.9 ± 0.1
Average female fetal crown rump length (cm) per litter 10.2 ± 0.1 10.0 ± 0.1 9.9 ± 0.2 9.8 ± 0.1
Bartlett’s (p = 0.3450); DOSE (p = 0.3230); SEX (p = 0.0001); DOSE  SEX (p = 0.6923).
Values reported as the mean ± SEM, or mean followed by percent in parentheses.
a lncludes all does pregnant at sacriﬁce. Litter size represents the number of implantation sites per doe.
b ‘‘Non-live’’ includes late fetal deaths plus resorptions.
c ‘‘Adversely affected’’ includes non-live plus malformed.
d lncludes only does with live fetuses. Litter size represents the number of live fetuses per doe. Two does each in the 0%, 2.5% and 10% groups had 100% resorptions; one doe
in the 5% group had 100% resorptions.
# Bartlett’s test for homogeneity of variances was either statistically signiﬁcant (p < 0.001) or there was zero variance in one or more groups so the test could not be done
and/or the test for normality was rejected for the majority of the groups, therefore nonparametric statistical tests were employed for evaluation of the data.
§ p < 0.05; Test for Linear Trend.
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There were no statistically signiﬁcant trends or pairwise com-
parisons for daily feed consumption, or for any larger interval val-
ues from day-14 to GD 30 (Table 4). There were, however, some
signiﬁcant (p < 0.05) trends for feed consumption prior to EPG
exposure.
Mean EPG intakes (Table 5), calculated from feed intake, mean
body weight, and EPG concentration in the diet, ranged from:
0.93 to 1.44 g/kg day in the 2.5% EPG group; 2.05–2.81 g/kg in
the 5% EPG group; and 4.06–5.59 g/kg bw/day in the 10% EPG
group.
3.5. Gestational parameters
There were no signiﬁcant treatment- or concentration-related
trends and no signiﬁcant pairwise comparisons of the treated
groups to the concurrent control group for any gestational param-
eters. These included: ovarian corpora lutea; uterine implantation
sites (total, early and late resorptions, dead fetuses); pre- and post-implantation loss; non-live (resorptions plus dead fetuses) or
adversely affected (non-live plus malformed) implants; live
fetuses; and male, female fetuses (Table 6).
There were trends toward lower mean fetal body weight and
crown rump length per litter among EPG groups, in a concentra-
tion-related manner. However, pairwise comparisons to the con-
current control group did not show signiﬁcance for any of these
parameters (Table 6). The effect was more pronounced in the case
of fetal body weights (all fetuses; males and females separately).
Since the differences were not statistically signiﬁcant, and the val-
ues were above or within the laboratory’s historical control values
for average fetal weights (data not shown), it was not possible to
establish a deﬁnitive relationship to the test substance. The labora-
tory had no in-house historical control data on rabbit fetal crown–
rump length.
3.6. Fetal malformations and variations
There were no statistically signiﬁcant or treatment-related dif-
ferences among groups in the incidence of fetal malformations or
Table 7
Summary of observations for fetuses and litters with at least one malformation or variation.
% EPG in feed
0 2.5 5 10
Total fetuses examineda 83 78 117 89
Malformations External 0 0 0 0
Skeletalc 1 (1.2%) 0 0 0
Visceralc 4 (4.8%) 2 (2.6%) 1 (0.9%) 2 (2.2%)
Total number of fetuses affectedg 5 (6%) 2 (2.6%) 1 (0.9%) 2 (2.2%)
Variations Externalc 1 (1.2%) 0 0 0
Skeletalc 44 (53%) 43 (55.1%) 71 (60.7%) 65 (73%)
Visceralc 3 (3.6%) 6 (7.7%) 7 (6%) 6 (6.7%)
Total number of fetuses affectedg 44 (53%) 47 (60.3%) 73 (62.4%) 68 (76.4%)
Total litters examinedb 12 13 17 13
Malformations External 0 0 0 0
Skeletald 1 (8.3%) 0 0 0
Viscerald 3 (25%) 2 (15.4%) 1 (5.9%) 2 (15.4%)
Total number of litters affectedg 4 (33.3%) 2 (15.4%) 1 (5.9%) 2 (15.4%)
Variations Externald 1 (8.3%) 0 0 0
Skeletald 9 (75%§) 12 (92.3%) 15 (88.2%) 13 (100%)
Viscerald 2 (16.7%) 5 (38.5%) 5 (29.4%) 4 (30.8%)
Total number of litters affectedg 9 (75%)§ 13 (100%) 15 (88.2%) 13 (100%)
Fetuses with malformations (per litter)c,e
Total 0.42 ± 0.19 0.15 ± 0.10 0.06 ± 0.06 0.15 ± 0.10
% 5.85 ± 2.75 2.05 ± 1.44 1.18 ± 1.18 3.46 ± 2.36
Males 0.18 ± 0.12 0.08 ± 0.08 0.06 ± 0.06 0
% Males 5.30 ± 3.60 2.56 ± 2.56 1.47 ± 1.47 0
Females 0.25 ± 0.13 0.08 ± 0.08 0 0.15 ± 0.10
% Females 7.22 ± 3.89 1.04 ± 1.04 0 4.49 ± 3.07
Fetuses with variations (per litter)c,f
Total 3.67 ± 0.91 3.62 ± 0.64 4.29 ± 0.72 5.23 ± 0.68
% 52.97 ± 10.74 60.47 ± 7.64 61.92 ± 9.15 74.26 ± 5.83
Males 1.82 ± 0.62 1.92 ± 0.37 2.18 ± 0.60 2.67 ± 0.43
% Males 48.48 ± 12.45 59.74 ± 9.44 59.71 ± 10.93 78.17 ± 7.23
Females 2.00 ± 0.52 1.83 ± 0.42 2.12 + 0.43 2.77 ± 0.38
% Females 55.42 ± 11.82 68.40 ± 10.45 61.90 ± 9.61 78.21 ± 7.16
Values reported as the mean ± SEM, or mean followed by percent in parentheses.
a Only live fetuses were examined.
b lncludes only litters with live fetuses.
c Fetuses with one or more malformation or variation.
d Litters with one or more malformation or variation.
e Bartlett’s DOSE (p = 0.1991); SEX (p = 0.6711); DOSE  SEX (p = 0.6141).
f Bartlett’s (p = 0.3972); DOSE (p = 0.3864); SEX (p = 0.4010); DOSE  SEX (p = 0.9347).
g A single fetus or litter may be represented more than once in listing individual defects.
§ p < 0.05; Cochran-Armitage Test for Linear Trend on Proportions.
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cant trend test (p < 0.05, Cochran–Armitage Test for Linear Trend
on Proportions) for percent litters with variations (Table 7). How-
ever, there was no dose-response pattern, and pairwise compari-
sons vs. the control group were not statistically signiﬁcant. The
historical control value for the same parameters (percent litters
with variations; data not shown), was 92.8% (7.7 of 83 litters).
The incidence and severity of the fetal malformations and varia-
tions (Table 8) observed in this study were not signiﬁcantly differ-
ent among groups.4. Discussion
Administration of EPG at levels of 2.5%, 5%, and 10% of diet to
rabbits beginning 1 week prior to insemination and continuing
through the period of major organogenesis resulted in no maternal
or developmental toxicity. A signiﬁcant concentration-related
downward trend was observed for maternal weight change only
for day-7 to GD 0 (the ﬁrst week of dietary exposure, prior to
insemination), but with no signiﬁcant pairwise comparisons to
the concurrent control group. For maternal feed consumption, sig-
niﬁcant dose-related downward trends were observed at various
intervals, but only prior to EPG exposure, and with no signiﬁcantpairwise comparisons. There were also no treatment- or concentra-
tion-related differences in the incidence or severity of maternal
clinical observations.
Developmental toxicity parameters were statistically equiva-
lent across all groups. For gestational parameters, there were
apparent concentration-related downward trends for fetal body
weights/litter and crown–rump length/litter (calculated for all live
fetuses and for males and females separately); only male fetal body
weights per litter exhibited a statistically signiﬁcant trend
(p < 0.05). Again, there were no statistically signiﬁcant pairwise
comparisons vs. control group. All of the mean fetal weight values
in this study were above or within the historical control
means ± 95% conﬁdence interval.
Analyses of fetal ﬁndings (i.e., malformations and variations),
showed no signiﬁcant differences among groups for any parameter
evaluated, including incidence of malformations or variations by
category. The only statistically signiﬁcant ﬁnding was a concentra-
tion-related upward trend (p < 0.05) for percent litters with any
variations. The relationship to EPG is uncertain because: the control
value (75%) was below the historical control value (92.8%); there
was no clear dose-response; and there were no signiﬁcant trends
or pairwise comparisons in any of the other categories of variations.
The incidence of some skeletal variations, speciﬁcally extra
rib(s) at lumbar vertebra 1, was slightly greater among EPG groups,
Table 8
Incidence of all fetal morphological observations.
% EPG in feed
0 2.5 5 10
Fetuses Litters Fetuses Litters Fetuses Litters Fetuses Litters
Skeletal malformations
Fused ribs 1 1
Fused rib cartilage 1 1
Visceral malformations
Agenesis of the gall bladder 3 3 2 2 1 1
Gall bladder 1=4 normal size 3 3 1 1 1 1
External variations
Hematoma: face 1 1
Skeletal variations
Rib on lumbar 1: bilateral full 34 8 31 11 55 15 47 12
Left full 3 3 5 5 10 5 5 4
Right full 1 1 1 1 4 4
Bilateral rudimentary 4 4 3 2 3 3 6 4
Left rudimentary 2 2 1 1 1 1
Right rudimentary 2 2 2 2 5 3 4 3
Visceral variations
Enlarged lateral ventricle of the brain (full): bilateral 1 1 1 1
Enlarged lateral ventricle (full): left 1 1 2 2 2 1
Enlarged lateral ventricle (full): right 1 1
Enlarged lateral ventricle of the brain (partial): left 1 1
Enlarged lateral ventricle (partial): right 1 1
Abnormal number of papillary muscles 2 2 3 3 2 2
Bifurcated or trifurcated papillary muscle(s) 1 1
Gall bladder ½ normal size 2 2 1 1
Gall bladder twice normal size 1 1
Liver-like tissue attached to gall bladder 1 1 1 1
Values represent the number of fetuses and litters in which the effect was seen. A blank cell indicates the effect was not observed in that group. A single fetus may be
represented more than once in listing individual defects. Only live fetuses and litters with live fetuses were examined.
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common variation observed in these types of studies, and was
reported to be the most common variation observed in term rabbit
fetuses in the laboratory’s historical control data.
The trends observed in the absence of any speciﬁc effects in any
group at any time for both maternal and developmental toxicity
might have been related, at least in part, to mild inanition at the
top concentration; an effect not directly related to EPG, but to its
presence as a no- or low-calorie component of the diet. Consider,
for example, that control animals received a diet consisting of
94% feed (plus 6% corn oil), whereas animals at the highest EPG
level received a diet consisting of 84% feed (plus 6% corn oil plus
10% EPG).
5. Conclusion
Based on the results of this study, a no-observable-adverse-
effect level (NOAEL) of 10% EPG (approximately 4.76 g/kg bw/
day) for both maternal and developmental toxicity in rabbits is
proposed.
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